Direxion Daily S&P Biotech Bear 3X ETF (LABD)

Funds & ETFs·etf
$7.52
-8.74% today
Prices delayed about 15 minutes · cached page, can be an hour old or more
Market Census Score
33/ 100
Score level
Below average
4 of 6 checks had data

Score for how it compares with the broader market is near the bottom of its range.

LABD scores higher than 4% of the 5,673 tickers we compare it with (Funds & ETFs).

As of 9 October 2026, Direxion Daily S&P Biotech Bear 3X ETF (LABD) scores 33 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated · scores usually change about once a day

Company finances: does not apply to this asset classInsider trades: does not apply to this asset classTrendStrengthFinancialsCompany finances: does not apply to this asset classInsidersInsider trades: does not apply to this asset classMarketMomentum33/ 100

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume
1.51× 30-day average
52-week range
5.81 – 36.72
Market cap
—
Earnings date
—
Volume
35,099,773
Avg. volume (30d)
23,221,838
Open
8.22
Previous close
8.24
Day's range (regular session)
7.40 – 8.29

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta
-2.46
P/E (TTM)
—
EPS (TTM)
—

Score breakdown · six named factors

Price trend
30
Strength vs the market
0
Company finances
—
Insider trades
—
Market mood
50
Recent momentum
31

Each bar is one part of the score, from 0 to 100. Read what the score means.

What the score says about LABD right now

Direxion Daily S&P Biotech Bear 3X ETF (LABD) currently scores 33/100 on the Market Census six-factor composite, at the Below average score level. LABD is -8.74% on the day and -0.07% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of LABD's data reads poorly than well. The level is a "look before you act" flag. It is not advice. LABD's strongest factor is market mood at 50/100 — a fairly good read on the overall market. The market mood is the same for every ticker at a given moment, so it says nothing about LABD itself. The weakest factor is strength vs the market at 0/100 — well below average next to the wider market.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See LABD in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Recent LABD news

No recent headlines name Direxion Daily S&P Biotech Bear 3X ETF.

Saved snapshot; the news and prices on this page can be an hour old or more.

Similar setups in Funds & ETFs right now

Six funds & etfs tickers whose composite scores are closest to LABD’s 33, all within 1 point.

Sorted by closeness to LABD’s composite score within Funds & ETFs. Saved snapshot; can be an hour old or more. Run the full scanner →

Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.